The following questions are designed to test your knowledge of SPIOLTO® RESPIMAT® and COPD, to support your learning and check your understanding.
The questions are intentionally challenging, providing you an opportunity to really test your own knowledge of these topics.
Test your knowledge
Test your knowledge with the quiz questions below.
What types of drugs are tiotropium and olodaterol?
What is the recommended daily dose of SPIOLTO® RESPIMAT®?
In which GOLD stage is lung function decline most rapid in COPD?
In the WISDOM study, which criteria have been identified that show which patients benefit from the addition of an ICS to SPIRIVA plus a LABA?
What are potential long term safety risks of ICS (inhaled corticosteroids)?
What are the key treatment goals of COPD according to the 2017 GOLD strategy report?
What steps are required for the daily use of RESPIMAT®?
What efficacy could SPIOLTO RESPIMAT demonstrate compared with SPIRIVA?
What is the most common adverse event seen with SPIOLTO® RESPIMAT®?
How are patients grouped according to the new GOLD guidelines?
When should treatment of COPD be initiated?
How does SPIOLTO® RESPIMAT® deliver the drug deep into the lungs?
Which of the following statements reflects the safety profile of SPIOLTO® RESPIMAT® compared to SPIRIVA®?
What level of improvement in total score can be observed for SPIOLTO® RESPIMAT® vs placebo using the St. George’s Respiratory Questionnaire (SGRQ)?
SPIOLTO® RESPIMAT® has demonstrated efficacy across all major components of COPD. In which group of patients can the greatest improvement be seen?
See what others say
Let us know your thoughts and see how others answered with the quick polls below.